Abstract | BACKGROUND/AIMS: METHODS: RESULTS: In NRK-52E cells, AKF-PD reduced AngII induced expressions of ROS, NOX2, fibronectin, collagen I (a1) and p-ERK. In UUO kidney cortex, AKF-PD attenuated the degree of renal interstitial fibrosis, which was associated with reduced the expressions of collagen I (a1) and fibronectin. Furthermore, AKF-PD downregulated the expressions of NOX2, MDA and p-ERK. CONCLUSION: AKF-PD treatment inhibits the progression of renal interstitial fibrosis by suppressing oxidative stress and ERK/MAPK signaling pathway.
|
Authors | Jiao Qin, Wen-Juan Mei, Yan-Yun Xie, Ling Huang, Qiong-Jing Yuan, Gao-Yun Hu, Li-Jian Tao, Zhang-Zhe Peng |
Journal | Kidney & blood pressure research
(Kidney Blood Press Res)
Vol. 40
Issue 1
Pg. 89-99
( 2015)
ISSN: 1423-0143 [Electronic] Switzerland |
PMID | 26029782
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 5-methyl-1-(3-fluorophenyl)-2-(1H)-pyridone
- Membrane Glycoproteins
- Pyridones
- Cybb protein, rat
- NADPH Oxidase 2
- NADPH Oxidases
|
Topics |
- Animals
- Fibrosis
- Gene Expression Regulation, Enzymologic
- Kidney Diseases
(drug therapy, enzymology, pathology)
- MAP Kinase Signaling System
(drug effects, physiology)
- Male
- Membrane Glycoproteins
(antagonists & inhibitors, biosynthesis)
- NADPH Oxidase 2
- NADPH Oxidases
(antagonists & inhibitors, biosynthesis)
- Oxidative Stress
(drug effects, physiology)
- Pyridones
(pharmacology, therapeutic use)
- Rats
- Rats, Sprague-Dawley
|